# Filing Detail

Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0001171843-16-010288
Filing Date
2016-05-24
Accepted
2016-05-24 16:05:15
Documents
3
Effectiveness Date
2016-05-24

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFR14A | defr14a_052416.htm | DEFR14A | 26524
2 | GRAPHIC | pcard_1.jpg | GRAPHIC | 315111
3 | GRAPHIC | pcard_2.jpg | GRAPHIC | 350989
| Complete submission text file | 0001171843-16-010288.txt |  | 945085

Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

EIN.: 043145961 | State of Incorp.: MA | Fiscal Year End: 1231
Type: DEFR14A | Act: 34 | File No.: 001-14027 | Film No.: 161671917
SIC: 3841 Surgical & Medical Instruments & Apparatus